Logo image
Morphological Study of the Effects of the GnRH Superagonist Deslorelin on the Canine Testis and Prostate Gland
Journal article   Peer reviewed

Morphological Study of the Effects of the GnRH Superagonist Deslorelin on the Canine Testis and Prostate Gland

A. Junaidi, P.E. Williamson, T.E. Trigg, J.M. Cummins and G.B. Martin
Reproduction in Domestic Animals, Vol.44(5), pp.757-763
2009
url
Link to Published Version *Subscription may be requiredView

Abstract

Contents The present study is part of a programme of research designed to evaluate the efficacy of the GnRH superagonist, deslorelin (d-Trp 6-Pro 9-des-Gly 10-LHRH ethylamide), as a contraceptive for male dogs. Adult dogs were assigned to a completely randomized design comprising six groups of four animals. Each dog in the control group received a blank implant (placebo) and each dog in the other five groups received a 6 mg deslorelin implant. One group of deslorelin-treated dogs was sacrificed on each of days 16, 26, 41, 101 and 620, and testicular and prostate tissues were collected for study by light and electron microscopy. On days 16 and 26 after implantation, we observed partial disruption of the seminiferous tubules, with early spermatids shed into the lumen. On days 41 and 101 after implantation, 90-100% of the seminiferous tubules were atrophic and aspermatogenic. On day 101 after implantation, 99% of all sections showed atrophy of the epithelium and shrinkage of epithelial height in the ductus epididymides. On days 41 and 101 after implantation, prostate tissue showed complete atrophy of the glandular epithelium (100% of sections) and an apparent increase in the relative proportion of connective tissue. At the electron microscopic level, in dogs treated with deslorelin for 41 and 101 days, the Sertoli cells were smaller and their nucleoli appeared smaller than in the control dogs. The nucleoli of the Leydig cells were atrophied and prostate glandular epithelium showed reduced epithelial height, atrophy of the nucleolus and an absence of secretory granules. Tissues collected during the recovery phase revealed a complete recovery of spermatogenesis. In conclusion, slow-release implants containing deslorelin induce a striking atrophy of the testes and prostate gland by 26 days after implantation, explaining the previously reported loss of ejaculate and arrest of sperm output. At histological level, the entire process appears to be completely reversible, in accordance with data on endocrine variables and semen production.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
3 Agriculture, Environment & Ecology
3.232 Veterinary Sciences
3.232.1281 Veterinary Reproductive Health
Web Of Science research areas
Agriculture, Dairy & Animal Science
Reproductive Biology
Veterinary Sciences
ESI research areas
Agricultural Sciences
Logo image